ALLMedicine™ Atrial Tachycardia Center

Oct 3rd, 2022 - Although it is common for bi-atrial tachycardia (AT) circuits to include the Bachmann bundle, there are few reports of its role in left AT circuits. A 77-year-old man was admitted for recurrent AT with a cycle length of 425 milliseconds. The endoc...

Sep 30th, 2022 - Catheter ablation of the cavotricuspid isthmus (CTI) is an effective and safe procedure in patients with atrial flutter (AFL) with excellent long-term results in preventing AFL recurrences. However, new-onset atrial fibrillation (AF) commonly deve...

Sep 25th, 2022 - The macroreentrant atrial tachycardia is very frequent in the adults with congenital heart disease. The impact of the arrhythmias on this type of patients is related to several factors: the anatomy and physiopathology of the specific congenital he...

Sep 23rd, 2022 - VISITAG SURPOINT (VS)-guided ablation of paroxysmal atrial fibrillation has demonstrated good short- and long-term success rates with low rates of complications in recent, predominantly European, studies. However, there is a lack of multicenter da...

Sep 23rd, 2022 - Arrhythmias are common in single ventricle patients though their effect on outcomes during stage I palliation (S1P) is unclear. The authors sought to study associated risks for arrhythmia in patients undergoing S1P for single ventricle disease and...

Sep 30th, 2022 - Catheter ablation of the cavotricuspid isthmus (CTI) is an effective and safe procedure in patients with atrial flutter (AFL) with excellent long-term results in preventing AFL recurrences. However, new-onset atrial fibrillation (AF) commonly deve...

Sep 7th, 2022 - Prospective, non-randomized, post market clinical evaluation of the VISITAG SURPOINT™ Module with External Processing Unit (EPU) when used with STSF catheter and ST catheter compared to an historical control performance goal. A maximum of 330 subj...

Sep 7th, 2022 - The purpose of this study is to measure the long term effectiveness，clinical benefit, and safety outcomes of catheter ablation with STSF and AI for paroxysmal atrial fibrillation (PAF) subjects up to 12-month follow-up. Subject:Up to 150 PAF subj...

Sep 6th, 2022 - Catheter based mapping of the electrical signals in the heart during atrial tachycardia can identify areas that require ablation in order to treat the arrhythmia. There are numerous methods by which to map atrial tachycardia. Isthmus guided ablati...

Sep 2nd, 2022 - A prospective cohort study to evaluate the association between various triggers encountered in daily life and induction of atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia and premature atrial contractions) with the use ...

Nov 15th, 2021 - In patients treated for persistent atrial fibrillation (AFib) with pulmonary vein antral isolation (PVAI), there was a numerical but not a statistical advantage for adjunctive left atrial appendage (LAA) ligation in a multicenter randomized trial.

Aug 24th, 2021 - A previously healthy infant who survived sudden cardiac arrest at home was later found to have a de novo likely pathogenic genetic mutation in the SOS1 gene, which might be an unrecognized cause of sudden infant death, report clinicians from Misso...

Nov 4th, 2020 - The VENUS trial results, which demonstrated a benefit of adding an ethanol infusion to the vein of Marshall during catheter ablation of persistent atrial fibrillation (AF), are now published. The results were first presented in March at the virtua...

Jul 29th, 2020 - One-year results with a radiofrequency balloon catheter to isolate pulmonary veins (PV) when treating paroxysmal atrial fibrillation (AF) show that 84% of patients remained free of AF and nearly as many were free of AF, atrial flutter, or atrial t...

Jul 29th, 2020 - One-year results with a radiofrequency balloon catheter to isolate pulmonary veins (PV) when treating paroxysmal atrial fibrillation (AF) show that 84% of patients remained free of AF and nearly as many were free of AF, atrial flutter, or atrial t...